It is estimated that epilepsy of unknown etiology constitutes one-third of all epilepsies in adults.
1 This represents a significant disease burden, with treatment limited to symptomatic antiseizure medications. A subgroup of these patients may have immune-mediated neuronal dysfunction.
1-3 Quiz Ref ID Recently, a number of neurological autoantibodies (Abs) have been described in association with autoimmune encephalopathy or epilepsy.
3 A majority of these antibodies are directed against neuronal cell surface antigens, including synaptic neurotransmitter receptors, ion channels, or related proteins. Another group of these patients have antibodies specific for intraneuronal nuclear or cytoplasmic antigens.
4,5 Additionally, patients with steroid-responsive encephalopathy associated with autoimmune thyroiditis or patients with high levels of glutamic acid decarboxylase 65 (GAD65) Abs can present with seizures.
6-9 Identification of these immune-mediated syndromes is important because early diagnosis and treatment appears to be associated with better clinical outcomes.